UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033550
Receipt number R000038258
Scientific Title Measurement of Carbohydrate-deficient transferrin in chronic liver disease; the prospective study
Date of disclosure of the study information 2018/08/01
Last modified on 2022/08/03 13:55:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Measurement of Carbohydrate-deficient transferrin in chronic liver disease; the prospective study

Acronym

Measurement of Carbohydrate-deficient transferrin in chronic liver disease; the prospective study

Scientific Title

Measurement of Carbohydrate-deficient transferrin in chronic liver disease; the prospective study

Scientific Title:Acronym

Measurement of Carbohydrate-deficient transferrin in chronic liver disease; the prospective study

Region

Japan


Condition

Condition

chronic liver disease

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to analyze the correlation of measured value of CDT and amount of drinking

Basic objectives2

Others

Basic objectives -Others

to confirm the usefulness of CDT in diagnosis of liver diseases

Trial characteristics_1


Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

measured value of CDT

Key secondary outcomes

pathological findings of liver biopsy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

liver biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.the patients who agree with participation in this study by their free will and write the agreement document as well after they are explained enough about the study.
2.the patients whose amount of drinking is well-defined.

Key exclusion criteria

1.the patients whose amount of drinking in not well-defined.
2.the patients who are judged inappropriate for this study by the principal investigator.
3.the patients who refuse to participate in this study.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Kenichi
Middle name
Last name Ikejima

Organization

Juntendo University School of Medicine

Division name

Department of Gastroenterology

Zip code

113-8431

Address

3-1-3 Hongo Bunkyo-ku Tokyo Japan

TEL

03-3813-3111

Email

ikejima@juntendo.ac.jp


Public contact

Name of contact person

1st name Kenichi
Middle name
Last name Ikejima

Organization

Juntendo University School of Medicine

Division name

Department of Gastroenterology

Zip code

113-8431

Address

3-1-3 Hongo Bunkyo-ku Tokyo Japan

TEL

03-3813-3111

Homepage URL


Email

ikejima@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo hospital IRB

Address

3-1-3 Hongo Bunkyo-ku Tokyo, Japan

Tel

03-5802-1584

Email

kenkyu5858@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部消化器内科(東京都)、順天堂大学医学部附属練馬病院(東京都)、順天堂大学医学部附属浦安病院(千葉県)、順天堂大学医学部附属静岡病院(静岡県)、東部地域病院(東京都)、順天堂大学医学部附属東京江東高齢者医療センター(東京都)、東京臨海病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 06 Month 01 Day

Date of IRB

2018 Year 05 Month 31 Day

Anticipated trial start date

2018 Year 08 Month 06 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 07 Month 28 Day

Last modified on

2022 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038258


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name